Immunologic parameters as significant prognostic factors in lung cancer

Lung Cancer

Volumn 37, Issue 2, 2002, Pages 161-169

  Nakamura, Haruhiko ^a   Saji, Hisashi ^a   Ogata, Akihiko ^a   Hosaka, Makoto ^a   Hagiwara, Masaru ^a   Kawasaki, Norihiko ^a   Konaka, Chimori ^a   Kato, Harubumi ^a  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

CD4; CD8; HLA DR; Lung cancer; Prognostic factors; Survival; Tumor immunity

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FC RECEPTOR; HLA DR ANTIGEN;

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL PARAMETERS; IN VITRO STUDY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; IMMUNOLOGY; LARGE CELL CARCINOMA; LUNG TUMOR; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; SMALL CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COMPARATIVE STUDY; FEMALE; HLA-DR ANTIGENS; HUMAN; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; T-LYMPHOCYTES; HUMANS; MIDDLE AGED;

EID: 0036021723     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00100-9     Document Type: Article

References (37)

1. Monitoring of immunologic status of patients receiving BCG therapy for malignant disease
2. Immunologic defects in lung cancer patients
3. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis
4. Immune reactivity in primary carcinoma of the lung and its relation to prognosis
5. Association of depressed postoperative lymphoproliferative responses to alloantigens with poor prognosis in patients with stage I lung cancer
6. Natural killer cell activity in lung cancer patients
7. Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients
8. Relationships between clinico-therapeutic parameters and immunological status in patients with lung cancer
9. Prognostic value of non-MHC-restricted killer cell activity in lung cancer
10. Prognostic factors from a randomized clinical trial in resected lung cancer
11. Regional lymph node classification for lung cancer staging
12. Cellular immunologic parameters related to age, gender, and stage in lung cancer patients
13. The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding
14. A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa
15. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer
16. Evaluation of phenotype of mononuclear host cells isolated from primary tumour and peripheral blood of patients with laryngeal carcinoma
17. Flow cytometric study of lymphocyte subsets in patients at different stages of colorectal carcinoma
18. Activated (HLA-DR+) T-lymphocyte subsets in early epithelial ovarian cancer and malignant ovarian germ cell tumors
19. Presence of activated T-cells with a T8+ M1+ Leu 7+ surface phenotype in invaded lymph nodes from patients with solid tumors
20. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: Correlations with survival following active specific immunotherapy
21. Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma
22. Prognostic factors in non-small cell lung cancer: Multiregression analysis in the National Cancer Center Hospital (Japan)
23. Prognostic factors in small-cell carcinoma of the lung: An analysis of 1,521 patients
24. Predictors of 5-year survival and curability in small cell lung cancer
25. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor for survival
26. Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience
27. Longer survival after resection of non-small cell lung cancer in Japanese women
28. Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612
29. The Fc receptors of normal and cancer patients monocytes
30. Increased expression of Fc gamma receptor in cancer patients and tumor bearing mice
31. Peripheral blood lymphocyte subsets and survival in small-cell lung cancer
32. Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line
33. Spontaneous regression of squamous cell lung carcinoma with adrenal metastasis
34. Cure of lung cancer from incomplete surgical resection
35. Spontaneous regression of bronchogenic carcinoma with five year survival
36. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies
37. Spontaneous 19-year regression of oat cell carcinoma with scalene node metastasis